14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $21.39 $27.42 Thursday, 2nd May 2024 ARWR stock ended at $24.13. This is 4.14% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 6.91% from a day low at $22.73 to a day high of $24.30.
90 days $21.39 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
May 07, 2021 $66.71 $67.50 $65.16 $66.38 623 371
May 06, 2021 $65.50 $66.04 $61.91 $65.66 914 753
May 05, 2021 $66.06 $68.65 $65.19 $66.47 923 060
May 04, 2021 $68.04 $70.06 $66.13 $66.48 808 017
May 03, 2021 $73.00 $73.98 $70.21 $70.24 559 253
Apr 30, 2021 $75.00 $77.28 $71.97 $72.76 899 392
Apr 29, 2021 $77.12 $77.12 $73.47 $75.76 607 358
Apr 28, 2021 $74.53 $76.71 $74.52 $75.96 721 615
Apr 27, 2021 $75.00 $75.41 $73.66 $74.52 663 489
Apr 26, 2021 $72.00 $74.93 $71.59 $74.50 653 906
Apr 23, 2021 $71.58 $72.35 $70.50 $71.59 558 985
Apr 22, 2021 $69.60 $72.15 $68.42 $70.99 711 769
Apr 21, 2021 $67.84 $69.24 $66.68 $69.03 554 573
Apr 20, 2021 $66.91 $68.86 $65.43 $68.12 466 516
Apr 19, 2021 $66.49 $68.45 $65.91 $67.00 537 964
Apr 16, 2021 $68.49 $69.47 $67.23 $67.65 632 069
Apr 15, 2021 $69.65 $69.70 $66.24 $67.98 720 699
Apr 14, 2021 $64.57 $68.22 $64.45 $67.17 648 737
Apr 13, 2021 $63.65 $64.70 $62.12 $63.93 406 897
Apr 12, 2021 $62.01 $62.90 $60.52 $62.78 493 278
Apr 09, 2021 $63.20 $63.25 $61.29 $62.15 783 255
Apr 08, 2021 $64.96 $65.74 $63.40 $63.71 399 010
Apr 07, 2021 $64.79 $65.45 $63.16 $63.39 517 427
Apr 06, 2021 $66.00 $67.56 $65.03 $65.15 411 672
Apr 05, 2021 $68.41 $69.11 $65.87 $67.22 461 264
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT